Brief: Urogen Pharma Reports Second Quarter 2022 Financial Results

UroGen Pharma

11/08/2022 14:59

Aug 11 (Reuters) - Urogen Pharma Ltd  UR8.F :
    * UROGEN PHARMA REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND
RECENT CORPORATE DEVELOPMENTS
    * Q2 LOSS PER SHARE $1.18
    * AS OF JUNE 30, 2022, CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES TOTALED $112.4 MILLION
    * REITERATES ANTICIPATED FULL YEAR 2022 NET PRODUCT REVENUES
FROM
JELMYTO TO BE IN RANGE OF $70 TO $80 MILLION

Source text for Eikon:  ID:nBw9SDyPka 
Further company coverage:  UR8.F 

 ((Reuters.Briefs@thomsonreuters.com;))